Dr. Robert Whitfield analyzed 700 explant samples and found bacterial contamination in 29%, lower than the 48% reported previously. The study didn't test whether biofilm causes capsular contracture, and molecular detection alone doesn't prove living organisms or infection are present.
You don't want to miss this about my research. It shows that 29% of explant specimens have bacterial contamination. Now, in the literature, there's always been this association or concern between that contamination and possible capsular contracture. Now, it does matter because in the literature previously, up to 48% had contamination, but in our study of almost 700, it was 29%. So the study was not designed to determine whether biofilm causes capsular contracture, Capsular contracture was not analyzed as a variable in it, and Bicker grade was not included. A relationship between microbial findings, biofilm, and capsular contracture has been proposed, but this study did not test or prove that. So these results count because sample size matters. Molecular detection does not by itself establish living organisms, mature biofilm, active infection, diagnosis, or causation. So please join me this Thursday, September 10th at 6 PM Central, 7 PM Eastern to discuss what the study measured, what it found, and what it really means as it regards to capsular contracture and the association. This is educational only. Individual care belongs always with your healthcare providers.
